688621.SHG Beijing Sun Novo Pharmaceutical Research Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
55.48 CNY
Close of Nov 5, 2026
46.51 80.40
Market cap
CNY 6.21B
P/E
924.7x
P/B
4.92x
ROE
-4.1%
Dividend yield
0.52%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688621.SHG undervalued?

Graham number

The Graham number of Beijing Sun Novo Pharmaceutical Research Co Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Beijing Sun Novo Pharmaceutical Research Co Ltd fundamental analysis

No fundamental analysis for Beijing Sun Novo Pharmaceutical Research Co Ltd yet.

Beijing Sun Novo Pharmaceutical Research Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Beijing Sun Novo Pharmaceutical Research Co Ltd

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates an external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; oncology, …

Full company profile